“RECENT ADVANCES IN IMMUNOTHERAPY AND TARGETED THERAPIES FOR HEPATOCELLULAR CARCINOMA (HCC): MOLECULAR MECHANISMS, CLINICAL PROGRESS, AND FUTURE DIRECTIONS”, rjnmsr, vol. 3, no. 8, pp. 48–83, Dec. 2025, doi: 10.63075/1ppc6219.